BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 34000365)

  • 1. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.
    Li Y; Ji X; Wu H; Li X; Zhang H; Tang D
    J Ethnopharmacol; 2021 Oct; 278():114207. PubMed ID: 34000365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota, a new frontier to understand traditional Chinese medicines.
    Feng W; Ao H; Peng C; Yan D
    Pharmacol Res; 2019 Apr; 142():176-191. PubMed ID: 30818043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.
    Li B; Xu M; Wang Y; Feng L; Xing H; Zhang K
    J Ethnopharmacol; 2023 Mar; 303():116038. PubMed ID: 36529248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota.
    Zhang HY; Tian JX; Lian FM; Li M; Liu WK; Zhen Z; Liao JQ; Tong XL
    Biomed Pharmacother; 2021 Jan; 133():110857. PubMed ID: 33197760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A protocol for systematic review and meta-analysis.
    Zheng Y; Ding Q; Zhang L; Gou X; Wei Y; Li M; Tong X
    Medicine (Baltimore); 2020 Sep; 99(38):e22233. PubMed ID: 32957365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.
    Cui H; Han S; Dai Y; Xie W; Zheng R; Sun Y; Xia X; Deng X; Cao Y; Zhang M; Shang H
    Phytomedicine; 2023 Aug; 117():154885. PubMed ID: 37302262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.
    Yue SJ; Wang WX; Yu JG; Chen YY; Shi XQ; Yan D; Zhou GS; Zhang L; Wang CY; Duan JA; Tang YP
    Pharmacol Res; 2019 Oct; 148():104453. PubMed ID: 31541688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effect of traditional Chinese medicine on gut microbiota in patients with atherosclerosis: A protocol for systematic review and meta-analysis.
    Huang L; Wang J; Xu R; Liu Y; Liu Z
    Medicine (Baltimore); 2020 Dec; 99(50):e23730. PubMed ID: 33327364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.
    Wu XQ; Zhao L; Zhao YL; He XY; Zou L; Zhao YY; Li X
    Pharm Biol; 2024 Dec; 62(1):423-435. PubMed ID: 38757785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary lipids, gut microbiota and lipid metabolism.
    Schoeler M; Caesar R
    Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.
    Qu W; Liu S; Zhang W; Zhu H; Tao Q; Wang H; Yan H
    Food Funct; 2019 Sep; 10(9):5886-5897. PubMed ID: 31464319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE
    Zhang Y; Gu Y; Chen Y; Huang Z; Li M; Jiang W; Chen J; Rao W; Luo S; Chen Y; Chen J; Li L; Jia Y; Liu M; Zhou F
    J Ethnopharmacol; 2021 Feb; 266():113436. PubMed ID: 33011372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.
    Chen Y; Wang M
    Drug Des Devel Ther; 2021; 15():4849-4863. PubMed ID: 34876807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The linkage of gut microbiota and the property theory of traditional Chinese medicine (TCM): Cold-natured and sweet-flavored TCMs as an example.
    Yang Y; Wu C
    J Ethnopharmacol; 2023 Apr; 306():116167. PubMed ID: 36641107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.
    Zheng Y; Ding Q; Wei Y; Gou X; Tian J; Li M; Tong X
    Phytomedicine; 2021 Jul; 88():153455. PubMed ID: 33478831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review.
    Gong X; Li X; Bo A; Shi RY; Li QY; Lei LJ; Zhang L; Li MH
    Pharmacol Res; 2020 Jul; 157():104824. PubMed ID: 32344049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of traditional Chinese medicine affecting gut microbiota in obesity.
    Li D; Tang W; Wang Y; Gao Q; Zhang H; Zhang Y; Wang Y; Yang Y; Zhou Y; Zhang Y; Li H; Li S; Zhao H
    Front Endocrinol (Lausanne); 2023; 14():1149751. PubMed ID: 36936157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
    Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.